ERIKA HARMON: Open Payments
NPI 1801567946 · SANTA MARIA, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,964 in 84 payments from 17 companies in 2025. Trend: 2023 $1,639 · 2024 $2,237 · 2025 $1,964
Food & beverage: $1,864Education: $100
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 7 | $391 |
| E.R. Squibb & Sons, L.L.C. | 16 | $364 |
| Janssen Biotech, Inc. | 11 | $192 |
| ABBVIE INC. | 9 | $191 |
| UCB, Inc. | 6 | $171 |
| Incyte Corporation | 9 | $146 |
| PFIZER INC. | 4 | $82 |
| Amgen Inc. | 5 | $79 |
| Arcutis Biotherapeutics, Inc. | 4 | $71 |
| Novartis Pharmaceuticals Corporation | 3 | $55 |
Products named: DUPIXENT, Sotyktu, TREMFYA, SKYRIZI, Bimzelx, OPZELURA, CIBINQO, OTEZLA.
Industry payments across CA — which companies pay providers there.
